[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371115-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371115-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tamoxifen-metabolites-acting-via-bkca-orchestrate-the-dynamics-of-k-and-ca2-in-breast-cancer-cells","Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells","","Tamoxifen metabolites drive breast cancer malignancy by modulating the large-conductance, voltage- and calcium-activated potassium channel BKCa. Using murine tumor-derived and human breast cancer cell models with a genetically encoded K+ indicator plus electrophysiology, the study identifies BKCa-dependent intracellular K+ signals and currents induced by clinically relevant TAM+M in an ER-independent manner. BKCa blockade reduces TAM+M-driven K+ current modulation, leading to altered intra- and extracellular Ca2+ mobilization via the TAM+M–BKCa axis. The findings support BKCa as an oncochannel shaping endocrine therapy outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tamoxifen-metabolites-acting-via-bkca-orchestrate-the-dynamics-of-k-and-ca2-in-breast-cancer-cells/371115/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tamoxifen-metabolites-acting-via-bkca-orchestrate-the-dynamics-of-k-and-ca2-in-breast-cancer-cells/371115.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do tamoxifen metabolites influence BKCa activity in breast cancer cells?","Question",{"text":63,"@type":64},"Clinically relevant tamoxifen metabolites (TAM+M) provoke BKCa-dependent intracellular K+ signals and currents in breast cancer cells, promoting malignancy in an ER-independent manner.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What happens when BKCa is genetically or pharmacologically blocked?",{"text":68,"@type":64},"Genetic or pharmacological blockade of BKCa significantly diminishes TAM+M-induced modulation of BKCa K+ currents, which also reduces intracellular K+ levels in breast cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"How does BKCa activation connect K+ changes to Ca2+ mobilization?",{"text":72,"@type":64},"Changes in K+ balance triggered intracellular and extracellular Ca2+ mobilization, indicating that the TAM+M–BKCa axis couples K+ homeostasis to Ca2+ signaling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371115,1790483986,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells  \nReceived for publication, January 26, 2025, and in revised form, November 13, 2025 Published, Papers in Press, December 6, 2025 [https://doi.org/10.1016/j.jbc.2025.1](https://doi.org/10.1016/j.jbc.2025.1)11015  \nSelina Maier 1,2, Werner Schroth2, Finn Mier3, Lucas Matt 1, Helmut Bischof1, Aiden Tamaddon 1,  \nDarko Stojkov 1, Lena Birkenfeld 1, Melanie Cruz Santos 1, Dominic Gross 1, Johanna Dahlen 1,  \nFlorian A. Büttner2, Irina Bonzheim4, Falko Fend4, Hiltrud Brauch2,5,6, Frank M. Boeckler3,7,  \nMatthias Schwab2,5,6,8, and Robert Lukowski 1, *  \nFrom the 1Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany; 2Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; 3Laboratory for Molecular Design and Pharmaceutical Biophysics, Institute of Pharmacy, University of Tübingen, Tübingen, Germany; 4Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany; 5Cluster of Excellence iFIT (EXC 2180)“Image-guided and Functionally Instructed Tumor Therapies”, University of Tübingen, Tübingen, Germany; 6German Cancer Consortium (DKTK) and German Cancer Research Center, Partner Site Tübingen, Tübingen, Germany; 7Interfaculty Institute for Biomedical Informatics (IBMI), University of Tübingen, Tübingen, Germany; and 8Departments of Clinical Pharmacology, and Biochemistry and Pharmacy, University of Tübingen, Tübingen, Germany  \nReviewed by members of the JBC Editorial Board. Edited by Mike Shipston  \nThe voltage- and calcium (Ca2+)-activated potassium (K+) channel of large conductance (BKCa) is aberrantly expressed in various breast cancer (BC) subtypes, including estrogen receptor (ER)-positive tumors. Increased proliferation of BC cells in response to tamoxifen (TAM) and its metabolites (TAM+M) has been shown to rely on the cell’s BKCa status. However, the mechanism by which TAM+M impact on BKCa activity to promote malignancy is yet not clear. By examining murine MMTV-PyMT tumor-derived BC cells and human BC cell lines with a genetically encoded K+ ion indicator and electrophysiological recordings, we identified BKCa-dependent intracellular K+ signals and currents provoked by treatment with clinically relevant TAM+M in an ER-independent manner. In line with this, genetical or pharmacological blockade of BKCa significantly diminished the TAM+Minduced modulation of BKCa K+ currents and consequently also the drop of intracellular K+ ions in BC cells. Changes in the K+ balance subsequently triggered intra-and extracellular Ca2+ mobilization, which was in turn stimulated by the TAM+M-BKCa axis. Our results highlight that BKCa “oncochannels” may modulate the response of BC cells to TAM+M. Activation of the TAM+M-BKCa axis causes significant changes in K+ and Ca2+ ion homeostasis, which ultimately contributes to the outcome of endocrine-based BC pharmacotherapy.  \nBreast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer-related death among women (1). BC comprises different subgroups based on the  \n* For correspondence: Robert Lukowski, robert.lukowski@uni-tuebingen. de.  \nPresent address for Helmut Bischof: Gottfried Schatz Research Center, Molecular Biology and Biochemistry, and Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.  \nexpression of the human epidermal growth factor receptor (HER2+), the progesterone receptor (PR+) and/or the estrogen receptor (ER+) or triple-negative BC (TNBC) (2). Classical treatment often includes surgery, radiotherapy and, depending on the type of tumor, cytotoxic as well as endocrine therapy (3). In pursue of novel prognosticators, predictors, and putative treatment targets, molecular expression profiles defined four intrinsic BC subtypes (i.e. LumA, LumB, HER2-enriched, basal) (4), and more recently, a s","cbCaihnFbwTYQrom","https://ap.wps.com/l/cbCaihnFbwTYQrom","pdf",8077430,18,"English","# Introduction\n## Breast cancer subtypes and endocrine therapy\n## Ion channels and BKCa as a potential target\n# Results and conclusions\n## TAM+M activates a BKCa-dependent K+–Ca2+ signaling axis\n## BKCa blockade links K+ balance shifts to Ca2+ mobilization","[{\"question\":\"How do tamoxifen metabolites influence BKCa activity in breast cancer cells?\",\"answer\":\"Clinically relevant tamoxifen metabolites (TAM+M) provoke BKCa-dependent intracellular K+ signals and currents in breast cancer cells, promoting malignancy in an ER-independent manner.\"},{\"question\":\"What happens when BKCa is genetically or pharmacologically blocked?\",\"answer\":\"Genetic or pharmacological blockade of BKCa significantly diminishes TAM+M-induced modulation of BKCa K+ currents, which also reduces intracellular K+ levels in breast cancer cells.\"},{\"question\":\"How does BKCa activation connect K+ changes to Ca2+ mobilization?\",\"answer\":\"Changes in K+ balance triggered intracellular and extracellular Ca2+ mobilization, indicating that the TAM+M–BKCa axis couples K+ homeostasis to Ca2+ signaling.\"}]","Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells | PDF",1790191281,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23a1ea695c1335a4bc5a0f2717d0658d.webp",983,1296,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/482ce34c30d8b5ff22382ec31101613a.webp",982,1294,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea62334eb641687dab65705f597ce64d.webp",981,1293,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b9fa661e42e2e4ae6547fcb08c1bd33.webp",980,1292]